Kim Adams

ORCID: 0000-0003-3051-8620
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Global Cancer Incidence and Screening
  • Head and Neck Cancer Studies
  • Vitamin C and Antioxidants Research
  • Tuberculosis Research and Epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Pharmacological Effects of Natural Compounds
  • Vitamin D Research Studies
  • Plant-based Medicinal Research
  • Pregnancy and Medication Impact
  • Cardiac electrophysiology and arrhythmias
  • Infectious Diseases and Tuberculosis
  • Hepatitis C virus research
  • Drug Transport and Resistance Mechanisms
  • Radiomics and Machine Learning in Medical Imaging
  • Climate Change and Health Impacts
  • Cardiomyopathy and Myosin Studies
  • Pregnancy and preeclampsia studies
  • Helicobacter pylori-related gastroenterology studies
  • Genomics, phytochemicals, and oxidative stress
  • Preterm Birth and Chorioamnionitis

University of Florida
2020

Columbus Oncology and Hematology Associates
2020

Stellenbosch University
2018-2020

Baptist Cancer Center
2018-2019

Massachusetts Institute of Technology
1986-1987

Boston University
1987

Abstract Para‐aminosalicylic acid (PAS), often the last drug remaining for treatment of drug‐resistant tuberculosis, is notorious causing gastrointestinal intolerance; however, cause PAS intolerance uncertain. The objective this study was to assess relationships between peak concentrations administered as a granular slow‐release enteric coated formulation, and its metabolites acetyl‐PAS glycine‐PAS, intolerance. were measured in 29 adult patients with tuberculosis at Brooklyn Hospital, Cape...

10.1002/jcph.1542 article EN The Journal of Clinical Pharmacology 2019-11-04

13 Background: Early detection of lung cancer provides the best opportunity for long-term survival. In 2021 US Preventive Services Task Force (USPSTF) expanded 2013 risk-based Low-dose CT (LDCT) screening criteria, in part to reduce unintended race and gender disparities detection. We evaluated impact updated USPSTF criteria a cohort patients from an incidental nodule program (ILNP). Methods: implemented ILNP community healthcare system mid-south US. Patients with lesions on...

10.1200/jco.2020.39.28_suppl.13 article EN Journal of Clinical Oncology 2021-09-21

8546 Background: Early detection reduces lung cancer (LC) mortality. We prospectively evaluated LC patients diagnosed through Lung Cancer Screening (LCS) or an Incidental Nodule Program (ILNP) (‘early detection’ programs) compared to routinely in a multidisciplinary program (MDP). Methods: compare demographics, tumor characteristics, and survival between the three groups within same healthcare system from 2015-2018. The ILNP tracks with suspicious lesions on routinely-performed studies...

10.1200/jco.2019.37.15_suppl.8546 article EN Journal of Clinical Oncology 2019-05-20

10.1016/s0002-9378(18)30726-9 article EN American Journal of Obstetrics and Gynecology 2018-09-28
Coming Soon ...